Assuming org is required, the following 67 results were found.
-
and approved vaccines, tests and treatments for COVID-19, flu and RSV. Content Original Link: https://www.idsociety.org/covid-19-real-time-learning-network/vaccines/vaccine-dosing--schedule/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Vaccinations
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Vaccinations
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Vaccinations
-
of the SARS-CoV-2 JN.1 variant Article Publication Date 3-Jan-2024 Content Original Link: https://www.eurekalert.org/news-releases/1033850
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
or if the heartbeat feels fluttery, fast or pounding after getting the vaccine. Content Original Link: https://www.mayoclinic.org/diseases-conditions/comparing-vaccines
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Vaccinations
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Medical News
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Vaccinations
-
Upload Step 1A Submission Step 1B: Download NLRA 2023-10 and Required Step 1B Forms (Invitation Only) CASIS will notify all offerors of the review results of their Step 1A: Concept Summary. Download Step 1B Required Forms Step 1B: Technology Roadmap Due...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
grant for study of early lesions $5.2M NIH grant bolsters colorectal cancer research Content Original Link: https://news.vumc.org/2023/12/08/vanderbilt-research-presented-at-cancer-moonshot-meet/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
scientists possible to deliver for patients and our society.” Read the full letter here. Content Original Link: https://phrma.org/Blog/RD-leaders-to-Biden-Administration-Your-policies-are-undermining-the-Cancer-Moonshot
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
those who are immunocompromised) would be expected to be the same risk groups in the setting of JN.1 infection (World Health Organization, December 2023; CDC, January 2024). Q: Will current vaccines protect against JN.1 infection and disease? A: Yes....
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
with those operated by the CDC and the Naval Medical Research Center (NMRC), responsible for specialized characterization of organisms, bioforensics, select agent activity, and handling highly infectious biological agents. It begs the question then,...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
biorisks at other labs. Now USAMRIID struggles to retain talent. Much of the work at USAMRIID is that of a contract research organization performing tasks for the private sector. “The concept that USAMRIID is more of an ‘insurance policy’ to deal with...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
analyze the disease course in tissue samples, the USAMRIID team discovered that while monkeypox virus was cleared from most organs—and from healed skin lesions—during convalescence, it could be detected for up to 37 days post-exposure in the testes of...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
Development Command. For more information, visit http://www.usamriid.army.mil. Content Original Link: https://www.eurekalert.org/news-releases/849956
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
Office of Community O We work with individuals and organizations across the state on projects to bring awareness to cancer prevention and screening and reduce health disparities. Projects include planning events, co-hosting workshops, sharing...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
schedules and care and helping them navigate any adverse events. It’s a demanding job that requires both intense focus and organizational skills, but Peters only has to glance at the scar that runs the length of her left arm to remember her own...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.